Survival after primary breast cancer surgery following propofol or sevoflurane general anesthesia-A retrospective, multicenter, database analysis of 6305 Swedish patients.

Mats EnlundAnders BerglundRebecca AhlstrandJakob Walldén Johan LundbergFredrik WärnbergAndreas EkmanNina Sjöblom WidfeldtAnna EnlundLeif Bergkvist

Published in: Acta anaesthesiologica Scandinavica (2020)

It seems that propofol may have a survival advantage compared with sevoflurane among breast cancer patients, but the inherent weaknesses of retrospective analyses were made apparent.

Keyphrases

end stage renal disease
minimally invasive
ejection fraction
chronic kidney disease
newly diagnosed
cross sectional
peritoneal dialysis
emergency department
coronary artery bypass
magnetic resonance imaging
acute coronary syndrome
patient reported outcomes
young adults
adverse drug
patient reported
free survival